Tag: SARS-CoV-2
Indian Immunologicals develops first-of-its kind needle-free COVID-19 intranasal vaccine
IIL in partnership with Griffith University, Australia developed needle free intra-nasal booster vaccine against SARS-CoV-2 using codon deoptimization technology
Could auto-antibodies be linked to severe COVID-19?
Researchers reveal auto-antibodies to type I IFNs block IFN signaling, contributing to severe COVID-19 by impairing the immune response
Fresh insights into spread of airborne pathogens in indoor spaces
Researchers at the Indian Institute of Technology Delhi, in a study, have demonstrated the role of aerosol dispersion of SARS-Cov-2 virus and similar airborne pathogens in the spread of the disease in enclosed spaces
New method of visual detection of SARS-CoV-2 can identify the infection...
Popularly used gold standard techniques such as RT-PCR and ELISA are usually time-consuming, require skilled labor, specific equipment and are not feasible for on-site detection
Genetic recombination made Omicron more infectious
The Indian researchers have found that recombination events had escalated during the Omicron wave, which made the virus more immune-evasive and infectious.
Researchers devise field deployable alternative to RT-PCR
The newly developed ‘Recombinase Polymerase Amplification (RPA)’ method, wherein all the reactions take place close to room temperature, does not require a thermal cycler
Researchers develop VLP-based vaccine candidate for Covid-19
A safer and easier strategy is to use virus-like particles (VLPs), the molecular mimics that look and act like a particular virus without being infectious
Exclusive: Antibody against multiple emerging SARS-CoV-2 variants
A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants
Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene partnership with Bharat Biotech &...
An entirely new “chimeric” spike antigen complex, different from any protein of existing SARS-CoV-2 variants, will be generated
How did COVID-19 spread during short conversations?
The simulations from a recent research showed that the risk of getting infected was higher when one person acted as a passive listener than when they engaged in a two-way conversation